Homocysteine and its role in the pathogenesis of atherosclerotic vascular disease

Area of Science:

• Cardiovascular Science
• Biochemistry
• Pathology

Background:

• Homocysteine is increasingly recognized as a risk factor for atherosclerotic vascular disease.
• Adverse effects of homocysteine on various cellular and molecular components of the vascular system have been extensively studied.
• Endothelial damage may be mediated by hydrogen peroxide, a homocysteine auto-oxidation byproduct.

Purpose of the Study:

• To review the evidence linking homocysteine to atherosclerotic vascular disease.
• To explore the mechanisms by which homocysteine may contribute to atherogenesis.
• To assess the clinical and epidemiological findings regarding hyperhomocysteinemia and vascular events.

Main Methods:

• Review of numerous studies investigating the influence of homocysteine on endothelial cells, vascular smooth muscle cells, and lipoproteins.
• Analysis of human studies examining the association between high homocysteine levels and endothelial-dependent vasodilation.
• Examination of retrospective and prospective studies on hyperhomocysteinemia and atheromatous events.

Main Results:

• High homocysteine levels are associated with impaired nitric oxide bioavailability and endothelial dysfunction.
• Homocysteine can contribute to the formation of oxidized LDL and foam cells, initiating atheromatous plaque development.
• Numerous studies indicate hyperhomocysteinemia is a risk factor for atherosclerotic disease and vascular events.

Conclusions:

• Homocysteine plays a significant role in the pathogenesis of atherosclerotic vascular disease through various mechanisms.
• Despite strong evidence, the extent to which homocysteine is a major risk factor for coronary heart disease remains debated in some research.
• Further investigation is warranted to fully elucidate the complex relationship between homocysteine and cardiovascular health.